Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. - Wikidata - awgldk - TriplyDB

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis.

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis.

http://www.wikidata.org/entity/Q34693160

about

Epigenetics Offer New Horizons for Colorectal Cancer Prevention Epigenetics of colorectal cancer Cross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic Acids New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies MicroRNAs as non-invasive screening biomarkers of colorectal cancer MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer MicroRNAs: Clinical Relevance in Colorectal Cancer Non-coding landscapes of colorectal cancer Prognostic Role of MicroRNA-200c-141 Cluster in Various Human Solid Malignant Neoplasms How microRNAs influence both hereditary and inflammatory-mediated colon cancers The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detection Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients Molecular biomarkers for the detection of metastatic colorectal cancer cells MiR-200, a new star miRNA in human cancer Bioinformatic tools for microRNA dissection MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers Circulating microRNAs in cancer: origin, function and application MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers Circulating microRNAs: potential biomarkers for common malignancies The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma Prognostic Role of the MicroRNA-200 Family in Various Carcinomas: A Systematic Review and Meta-Analysis Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.Principles of microRNA involvement in human cancers.Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan.Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs.Circulating miRNAs as new blood-based biomarkers for solid cancers.Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer.Regulation of cancer metastasis by cell-free miRNAs.

P2860

Q22252606-48E0E7D1-9EEF-4BD7-8A8C-9FF8C8FEB6A8 Q24598045-FE91B6EC-F0A5-4EC1-BF9C-2046F418FEE5 Q26744516-7CE37294-4CE6-4953-A584-3E0ACCA85DB3 Q26748881-76984333-2233-4894-83CB-75375264EC7B Q26770798-059ADCAF-55C4-4A85-AE13-87D5D611CF48 Q26775610-79CEE6F6-8570-4F01-A733-10582967F623 Q26776039-922C305E-1E9C-4973-86CC-D1297A5AF256 Q26778014-878522F0-551F-4665-9E61-7CE30E269582 Q26778084-61B2CDAB-02EF-4592-82AB-A45CD55C4CA5 Q26823451-96544A8F-A796-4EC2-9914-C2BD735F5E08 Q26825022-0C5B6983-EB74-4B6F-96C9-3ACBDAD6EAA8 Q26991998-5EB3F1FB-5D10-4632-B2D3-C9D845D6F2F6 Q26996424-81452512-866C-47FE-9E7C-9DEB1277664C Q27002450-FFDB3664-BCAB-4656-B212-991DAFC58F11 Q27004023-B761C4D8-70BD-4F70-A021-61E7EBF17E4C Q27004412-5704DDD7-8B20-4989-BBBA-0C482234F4B0 Q27006159-A9B730F7-755D-4B44-8201-AB418F3868BE Q27013716-3B1A0B05-773B-4B79-AD17-C653EB63588A Q27022048-B546F393-771A-4B08-9093-9F648B8E5570 Q27024427-0CAB6CEB-8D09-4423-9BFC-09E54C22528F Q28080153-4F959840-E01E-4937-BE5F-E1CA26FBAE06 Q28081347-3595AECA-4949-4C0A-A45F-8A8766C3F60A Q28083742-642D555E-2F87-4537-BF4E-320EB97E03B7 Q28389722-C87EC116-9316-4F44-A888-A8094FCA9FA9 Q30235175-D4968DCF-F2ED-492C-B552-8C91E4BC6EC6 Q33559304-4AB26695-C77A-4F03-8BE7-05541080A00E Q33579255-A9BA30CF-A26F-4B3C-8245-6FB0CB38A643 Q33654179-9B609339-526F-420A-9F92-B2B770FC208F Q33773806-ED78CF26-93B5-4141-85CB-5F5F3F22C2DB Q33779486-14DBAE1E-A097-4D9A-B7F8-E49F7F633A22 Q34002982-FEEC0FA1-08A7-4E47-A028-8F3055B68717 Q34331651-2684EB75-CE65-4407-BFF9-5F603DF6A71C Q34364165-18D6E6AA-E5F1-45D8-9333-4A9C225F7AB9 Q34412367-70D09105-ECE0-412A-AA60-7D308EEB265E Q34482118-2E8C9CAF-B2A0-49D3-8795-E46D89BBF03B Q34603514-5D9C7EB0-3C1F-41CD-A2C8-12521EC9995A Q34605730-29922E68-C4F3-4926-A631-E24ED41FFD9A Q34729935-D6DFD04A-082C-4A7C-9C8B-016E9C3F6ED9 Q35023641-37B9BE82-6BE0-4626-9EDC-33F18CA16FB3 Q35034340-5AF31A93-6289-414E-9470-D0A89AE63681

P2860

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis.

http://www.wikidata.org/entity/Q34693160

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Circulating plasma MiR-141 is ...... r and predicts poor prognosis.

@ast

Circulating plasma MiR-141 is ...... r and predicts poor prognosis.

@en

Circulating plasma MiR-141 is ...... r and predicts poor prognosis.

@nl

type

label

Circulating plasma MiR-141 is ...... r and predicts poor prognosis.

@ast

Circulating plasma MiR-141 is ...... r and predicts poor prognosis.

@en

Circulating plasma MiR-141 is ...... r and predicts poor prognosis.

@nl

prefLabel

Circulating plasma MiR-141 is ...... r and predicts poor prognosis.

@ast

Circulating plasma MiR-141 is ...... r and predicts poor prognosis.

@en

Circulating plasma MiR-141 is ...... r and predicts poor prognosis.

@nl

P1433

Q34693160-2C8D1144-5406-4171-9E8F-76EBBC0AFB5E

P1476

Q34693160-DC9E8378-2807-4DA1-919F-105AE8204312

P2093

Q34693160-0DAD805C-1CE6-4508-B200-8A8885867E4A

Q34693160-2D6156B8-4758-4837-9BA1-597D0913D110

Q34693160-2DDA8CED-8576-42D7-BA60-CA0536D9E632

Q34693160-6AC1FE69-E621-4B1A-BEB0-D70AF4D4F589

Q34693160-75D41E69-CD37-452C-AB92-DDC3056A18B2

Q34693160-A05CA9FB-92B6-49BE-897A-4250D27DCD0B

Q34693160-AA1C1A2C-F901-4819-885B-6C2CA3745E44

Q34693160-BD201263-712D-4E6B-B14B-4A03C59D6778

Q34693160-C282D89D-DBD5-4A6D-B8F1-99BA573C4B72

Q34693160-CDEFC087-01A4-48AC-BA09-A4B56800EF88

P2860

Q34693160-07D055A5-2E2A-44D4-8A06-9AC72B850E4E

Q34693160-10C7DE0F-2F96-40AD-B276-A4BF3ACAA90A

Q34693160-1750F0FF-EEA7-4104-88B0-F5FB595AE0E1

Q34693160-1A4B7DC6-7B62-49CE-A5D4-37A088BF831D

Q34693160-341BBA67-D3CC-49A3-9413-5560A4E1E373

Q34693160-42E9D6B1-CB8C-4653-B7C8-189DC48F23A5

Q34693160-57B174FF-C7FB-4BCF-BD0E-F0EA11C8FF83

Q34693160-6246EA71-B627-4243-99F7-A3389ABA4A1D

Q34693160-68816A2F-957B-4244-B8B9-BE798074A3DF

Q34693160-8A2624DB-5120-4D5A-BD49-C4729103921E

P304

Q34693160-D5D3FF6A-7A28-45FF-8BA5-FD86A0875412

P31

Q34693160-CD5A324F-AA94-42D3-BCA9-32693A7CFE01

P356

Q34693160-260E1737-014B-48BF-BF33-79933E7FA602

P407

Q34693160-D1C2E9C3-D20D-4F95-BADE-D8AD289CA1E1

P433

Q34693160-012D6256-8FA7-400F-987F-4DD5CEEA4DAB

P478

Q34693160-096BF1A2-0AB3-4C36-9F27-A4FB01882393

P577

Q34693160-60E8AA0B-A6FA-4A41-A316-D7B02F6A0B2E

P5875

Q34693160-6DCBB495-DEBA-46B8-8AAF-CE3D2450656A

P698

Q34693160-D324E2AF-4B86-4F05-84F3-98241E61D93F

P921

Q34693160-82CE9541-D0CB-41F1-AD85-684D4974C55F

P932

Q34693160-DA3EAF63-1CEC-4BC4-818B-FA6662453573

P356

JOURNAL.PONE.0017745

P1433

P1476

Circulating plasma MiR-141 is ...... r and predicts poor prognosis.

@en

P2093

Aaron J Schetter

http://www.w3.org/2001/XMLSchema#string

Curtis C Harris

http://www.w3.org/2001/XMLSchema#string

David E Cogdell

http://www.w3.org/2001/XMLSchema#string

Hanyin Cheng

http://www.w3.org/2001/XMLSchema#string

Hong Zheng

http://www.w3.org/2001/XMLSchema#string

Kexin Chen

http://www.w3.org/2001/XMLSchema#string

Lina Zhang

http://www.w3.org/2001/XMLSchema#string

Matti Nykter

http://www.w3.org/2001/XMLSchema#string

Stanley R Hamilton

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients

A microRNA expression signature of human solid tumors defines cancer gene targets

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

Circulating microRNAs as stable blood-based markers for cancer detection.

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas

Global cancer statistics, 2002

let-7 microRNA functions as a potential growth suppressor in human colon cancer cells

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

P304

e17745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0017745

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50892293

http://www.w3.org/2001/XMLSchema#string

P698

21445232

http://www.w3.org/2001/XMLSchema#string

P921

P932

3060165

http://www.w3.org/2001/XMLSchema#string